141 related articles for article (PubMed ID: 25292094)
1. Association of rs1219648 in FGFR2 and rs1042522 in TP53 with premenopausal breast cancer in an Iranian Azeri population.
Saadatian Z; Gharesouran J; Ghojazadeh M; Ghohari-Lasaki S; Tarkesh-Esfahani N; Mohaddes Ardebili SM
Asian Pac J Cancer Prev; 2014; 15(18):7955-8. PubMed ID: 25292094
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between the FGFR2 and TP53 genes in breast cancer: data from an association study and epistatic interaction analysis.
Cherdyntseva NV; Denisov EV; Litviakov NV; Maksimov VN; Malinovskaya EA; Babyshkina NN; Slonimskaya EM; Voevoda MI; Choinzonov EL
DNA Cell Biol; 2012 Mar; 31(3):306-16. PubMed ID: 21838531
[TBL] [Abstract][Full Text] [Related]
3. Lack of association of intron 3 16 bp polymorphism of TP53 with breast cancer among Iranian-Azeri patients.
Pouladi N; Kouhsari SM; Feizi MH; Dehghan R; Azarfam P; Farajzadeh D
Asian Pac J Cancer Prev; 2014; 15(6):2631-4. PubMed ID: 24761875
[TBL] [Abstract][Full Text] [Related]
4. The TP53 intron 6 G13964C polymorphism and risk of thyroid and breast cancer development in the Iranian Azeri population.
Dehghan R; Hosseinpour Feizi MA; Pouladi N; Adampourezare M; Farajzadeh D
Asian Pac J Cancer Prev; 2015; 16(7):3073-7. PubMed ID: 25854408
[TBL] [Abstract][Full Text] [Related]
5. An investigation of the effects of FGFR2 and B7-H4 polymorphisms in breast cancer.
Ozgöz A; Samli H; Oztürk KH; Orhan B; Icduygu FM; Aktepe F; Imirzalioglu N
J Cancer Res Ther; 2013; 9(3):370-5. PubMed ID: 24125968
[TBL] [Abstract][Full Text] [Related]
6. Risk of aggressive breast cancer in women of Han nationality carrying TGFB1 rs1982073 C allele and FGFR2 rs1219648 G allele in North China.
Chen XH; Li XQ; Chen Y; Feng YM
Breast Cancer Res Treat; 2011 Jan; 125(2):575-82. PubMed ID: 20640597
[TBL] [Abstract][Full Text] [Related]
7. A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India.
Siddiqui S; Chattopadhyay S; Akhtar MS; Najm MZ; Deo SV; Shukla NK; Husain SA
PLoS One; 2014; 9(10):e110426. PubMed ID: 25333473
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer.
Lin CY; Ho CM; Bau DT; Yang SF; Liu SH; Lin PH; Lin TH; Tien N; Shih MC; Lu JJ
Anticancer Res; 2012 Feb; 32(2):475-82. PubMed ID: 22287734
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.
Andersen SW; Trentham-Dietz A; Figueroa JD; Titus LJ; Cai Q; Long J; Hampton JM; Egan KM; Newcomb PA
Menopause; 2013 Mar; 20(3):354-8. PubMed ID: 23435034
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.
Mazhar A; Jamil F; Bashir Q; Ahmad MS; Masood M; Tanvir I; Rashid N; Waheed A; Afzal MN; Tariq MA
Mol Med Rep; 2016 Oct; 14(4):3443-51. PubMed ID: 27572905
[TBL] [Abstract][Full Text] [Related]
11. TP53 Gene Pro72Arg (rs1042522) Single Nucleotide Polymorphism as Not a Risk Factor for Colorectal Cancer in the Iranian Azari Population.
Asadi M; Shanehbandi D; Zarintan A; Pedram N; Baradaran B; Zafari V; Shirmohamadi M; Hashemzadeh S
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3423-3427. PubMed ID: 29286614
[TBL] [Abstract][Full Text] [Related]
12. Lack of influence of TP53 Arg72Pro and 16bp duplication polymorphisms on risk of breast cancer in Iran.
Gohari-Lasaki S; Gharesouran J; Ghojazadeh M; Montazeri V; Mohaddes Ardebili SM
Asian Pac J Cancer Prev; 2015; 16(7):2971-4. PubMed ID: 25854391
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Association between
Jahan N; Begum M; Barek MA; Aziz MA; Hossen MS; Bhowmik KK; Akter T; Islam MR; Abdulabbas HS; Islam MS
Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107577
[TBL] [Abstract][Full Text] [Related]
14. 14-bp Insertion/Deletion Polymorphism of the HLA-G gene in Breast Cancer among Women from North Western Iran.
Haghi M; Hosseinpour Feizi MA; Sadeghizadeh M; Lotfi AS
Asian Pac J Cancer Prev; 2015; 16(14):6155-8. PubMed ID: 26320511
[TBL] [Abstract][Full Text] [Related]
15. TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population.
Hossain A; Murshid GMM; Zilani MNH; Islam F; Sultana R; Sultana T; Hossain MG; Rahman MM
Breast Cancer; 2017 Jul; 24(4):571-578. PubMed ID: 27837441
[TBL] [Abstract][Full Text] [Related]
16. CYP1A1, GSTM1, GSTT1 and TP53 Polymorphisms and Risk of Gallbladder Cancer in Bolivians.
Sakai K; Loza E; Roig GV; Nozaki R; Asai T; Ikoma T; Tsuchiya Y; Kiyohara C; Yamamoto M; Nakamura K
Asian Pac J Cancer Prev; 2016; 17(2):781-4. PubMed ID: 26925680
[TBL] [Abstract][Full Text] [Related]
17. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
Wang ML; Xu YX; Qian J; Wang FH
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
[TBL] [Abstract][Full Text] [Related]
18. Haplotype and linkage disequilibrium of TP53-WRAP53 locus in Iranian-Azeri women with breast cancer.
Pouladi N; Abdolahi S; Farajzadeh D; Hosseinpour Feizi MA
PLoS One; 2019; 14(8):e0220727. PubMed ID: 31387111
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women.
Khadang B; Fattahi MJ; Talei A; Dehaghani AS; Ghaderi A
Cancer Genet Cytogenet; 2007 Feb; 173(1):38-42. PubMed ID: 17284368
[TBL] [Abstract][Full Text] [Related]
20. TP53 (rs1042522, rs28934571) and TP21 (rs1801270, rs1059234) Polymorphisms and Risk of Breast Cancer among Rural Women of Maharashtra: Findings from a Hospital Based Case- Control Study.
Datkhile KD; Bhosale SJ; Durgawale PP; Jagdale NJ; More AL; Gudur RA; Gudur AK; Patil SR
Asian Pac J Cancer Prev; 2023 May; 24(5):1611-1619. PubMed ID: 37247280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]